These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8549420

  • 1. Quinolone activity against anaerobes: microbiological aspects.
    Appelbaum PC.
    Drugs; 1995; 49 Suppl 2():76-80. PubMed ID: 8549420
    [Abstract] [Full Text] [Related]

  • 2. Quinolone activity against anaerobes.
    Appelbaum PC.
    Drugs; 1999; 58 Suppl 2():60-4. PubMed ID: 10553708
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of anaerobes to quinolones in the United States.
    Hecht DW, Wexler HM.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S2-8. PubMed ID: 8953099
    [Abstract] [Full Text] [Related]

  • 4. [Quinolones: historic review].
    Rothlin RP.
    Medicina (B Aires); 1999 Dec; 59 Suppl 1():3-7. PubMed ID: 10436548
    [Abstract] [Full Text] [Related]

  • 5. Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).
    Cormican MG, Marshall SA, Jones RN.
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):51-4. PubMed ID: 7789097
    [Abstract] [Full Text] [Related]

  • 6. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
    Goldstein EJ.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S25-30. PubMed ID: 8953103
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of grepafloxacin (OPC-17116) against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):129-33. PubMed ID: 7805357
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.
    Nord CE.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S15-8. PubMed ID: 8953101
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activity of DU-6859a against anaerobic bacteria.
    Wexler HM, Molitoris E, Reeves D, Finegold SM.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2504-9. PubMed ID: 7840599
    [Abstract] [Full Text] [Related]

  • 11. Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.
    Goldstein EJ, Citron DM, Hunt Gerardo S, Hudspeth M, Merriam CV.
    Antimicrob Agents Chemother; 1997 May; 41(5):1193-5. PubMed ID: 9145900
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    Barry AL, Jones RN.
    J Antimicrob Chemother; 1989 Apr; 23(4):527-35. PubMed ID: 2745259
    [Abstract] [Full Text] [Related]

  • 14. Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria.
    MacGowan AP, Bowker KE, Holt HA, Wootton M, Reeves DS.
    J Antimicrob Chemother; 1997 Oct; 40(4):503-9. PubMed ID: 9372419
    [Abstract] [Full Text] [Related]

  • 15. Newly documented antimicrobial activity of quinolones.
    Furet YX, Pechère JC.
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):249-54. PubMed ID: 1864284
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes.
    Aldridge KE, Ashcraft DS.
    Antimicrob Agents Chemother; 1997 Mar; 41(3):709-11. PubMed ID: 9056020
    [Abstract] [Full Text] [Related]

  • 17. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H, Hayakawa I, Akimoto T.
    Yakushigaku Zasshi; 2003 Mar; 38(2):161-79. PubMed ID: 15143768
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of three of the newer quinolones against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Antimicrob Agents Chemother; 1992 Jan; 36(1):239-43. PubMed ID: 1317149
    [Abstract] [Full Text] [Related]

  • 19. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL, Fuchs PC.
    J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
    [Abstract] [Full Text] [Related]

  • 20. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB, Swanson RN.
    Drugs Exp Clin Res; 1988 Feb; 14(6):375-8. PubMed ID: 3145851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.